<?xml version="1.0" encoding="UTF-8"?>
<p>Some of the vaccine candidates which proved to be protective in animal models were transferred to clinical testing in humans (
 <xref rid="T0001">Table 1</xref>). To date, clinical trials have been performed with a DNA vaccine, chimeric flaviviruses using the yellow fever vaccine strain or an attenuated DENV as backbones and a recombinant, insect-cell-derived E protein ectodomain.
 <sup>
  <xref rid="CIT0022">22</xref>â€“
  <xref rid="CIT0026">26</xref>
 </sup>
</p>
